Back

Device-related thrombus after percutaneous intervention for Atrial Septal Defect (ASD) and Patent Foramen Ovale (PFO)

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Patent foramen ovale closure Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Lukas Heusel

Freiburg (Germany)

7 More presentations in this session

Presentation thumbnail
A predictive score for supraventricular arrythmia after Patent Foramen Ovale percutaneous Closure
Professor J. Silvain (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Comparison of Amplatzer and Gore Cardioform occluder for patent foramen ovale closure in patients with nickel hypersensitivity
Doctor A. Apostolos (London, GB)
Abstract Slides Video
Presentation thumbnail
Prevalence and predictors of residual shunt in patient undergoing patent foramen ovale closure
Doctor S. Ragonese (Catania, IT)
Abstract Slides Video
Presentation thumbnail
Percutaneous closure of patent foramen ovale in refractory hypoxemia and platypnea-orthodeoxia syndrome 
Doctor G. Ndiaye (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Incidence of atrial fibrillation Post Patent forament Ovale (PFO) closure: a meta-analysis
Doctor E. Oikonomou (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Patent foramen ovale closure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
4-year follow-up results of percutaneous closure of atrial septal defect with the total biodegradable poly-L-lactic acid device: date from a prospective, single-center trial
thumbnail
Congress Presentation
Transoesophageal echocardiography with contrast bubble study directly after device placement to assess successful closure of PFO: a predictor for residual shunt at 6 months follow-up?
thumbnail
Congress Presentation
The incidence of atrial fibrillation in patients with interatrial shunt:is it reduced after surgical or transcatheter closure of the shunt?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources